Close Server: KOPWWW05 | Not logged in

Online Extras

Restech's Dx-pH Measurement System Receives CE Mark

Feb. 20, 2009

The Dx-pH Measurement System from Respiratory Technology Corp., San Diego, has received CE Mark approval, allowing introduction to the European Union and all countries recognizing the CE Mark. This approval certifies Restech has met E.U. health, safety, and environmental requirements that ensure consumer safety. 

Restech's Dx-System provides valuable information about patients' pharyngeal acid exposure and its role in various comorbidities, helping physicians diagnose the cause of the patient's symptoms more accurately, and treat the patient more effectively.

"The CE Mark approval is a result of our efforts and desire to bring this much needed technology to physicians worldwide," said Leo R. Roucher, chief executive officer of Restech. "In response to requests from the international community, we can now provide the technology to help diagnose and treat patients more quickly, comfortably, and effectively."

Market Matters Archives


Email: *

Email, first name, comment and security code are required fields; all other fields are optional. With the exception of email, any information you provide will be displayed with your comment.

First * Last
Title Field Facility
City State

Comments: *
To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the below image, reload the page to generate a new one.

Enter the security code below: *

Fields marked with an * are required.


Back to Top

© 2017 ADVANCE Healthcare, an Elite CE company